BPC-157, TB-500, GHK Basic, & KPV Blend

Also known as: KLOW Basic, KLOW (GHK Basic), Wolverine Basic

Available Suppliers & Pricing

No pricing information available for this peptide

Price-drop alert for BPC-157, TB-500, GHK Basic, & KPV Blend

Get an email when the lowest listed price falls below your target. No account required.

By setting an alert, you request catalog price-alert emails for this research-use-only product. Alerts are informational, not medical guidance. You can unsubscribe from any alert email.

Price history

Review recorded in-stock supplier catalog prices for BPC-157, TB-500, GHK Basic, & KPV Blend.

View price history →

Summary

BPC-157, TB-500, GHK Basic & KPV Blend has no established direct evidence for the exact multi-peptide combination. The defensible page should treat the blend as separate components with mostly preclinical research records. BPC-157 has rat tendon and tendon-to-bone data suggesting repair-related effects. TB-500 is commonly identified as the thymosin beta-4 fragment LKKTETQ, but stronger published evidence is for full-length thymosin beta-4 in wound-healing and angiogenesis models rather than for the commercial fragment itself. GHK or GHK-Cu research includes topical wound and connective-tissue remodeling studies. KPV has cell and mouse colitis data supporting anti-inflammatory mechanisms. None of these studies validates the combined blend.

Potential Benefits

Component Repair and Wound Models

BPC-157 tendon studies, full-length thymosin beta-4 wound-healing research, and GHK-Cu wound evidence support separate component-level repair biology contexts ^[1]^[2]^[3].

KPV Inflammation Models

KPV reduced inflammatory signaling and colitis severity in cell and mouse models ^[4].

Direct Blend Gap

No source evaluated the exact four-component blend, additive effects, dosing, or clinical usefulness.

Safety Information

FDA Component Cautions

FDA flags BPC-157, TB-500, KPV, and injectable GHK-Cu in the context of compounded bulk substances with significant safety concerns or insufficient human exposure data ^[5].

Multi-Peptide Uncertainty

Multi-peptide combinations can introduce interaction, impurity, and immune-response uncertainties not addressed by single-component studies.